Dexmedetomidine Completed Phase 3 Trials for Lidocaine (DB00281)

IndicationStatusPhase
DBCOND0050052 (Dexmedetomidine)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02987985Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing TonsillectomyPrevention